Assembly Biosciences, Inc. (ASMB) vs Cerus Corporation (CERS)

A side-by-side comparison of Assembly Biosciences, Inc. and Cerus Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ASMB vs CERS

growth of $100 · dividends reinvested · last 10y
ASMB -73.7% (-12.5%/yr)CERS -62.6% (-9.4%/yr)CERS compounded faster over this window
0200400600800Start $10020182020202220242026$26$37
ASMB CERS

ASMB vs CERS: by the numbers

  • •CERS is the larger company ($472M vs $451M market cap).
  • •Both run net losses; ASMB's is the smaller (-0.06% vs -3.06% net margin).
  • •CERS grew revenue faster over the past five years (15.74% vs -1.78% CAGR).

Metrics side by side

Valuation

MetricASMBCERS
P/E ratio41.35N/A
P/S ratio6.022.13
P/B ratio1.476.73
EV / EBITDAN/A8036.17

Profitability

MetricASMBCERS
Gross margin99.82%52.05%
Operating margin-11.75%-0.73%
Net margin-0.06%-3.06%
ROE-0.01%-9.69%
ROIC-2.86%-1.08%

Growth (annualized)

MetricASMBCERS
Revenue CAGR (5Y)-1.78%15.74%
Total return CAGR (5Y)-10.66%-17.30%

Frequently asked

Which has grown faster, ASMB or CERS?
Over the past five years, CERS grew revenue faster — ASMB at a -1.78% CAGR versus CERS at 15.74%.
How have ASMB and CERS total returns compared?
Over the past 10 years, ASMB delivered -13.41% and CERS delivered -9.37% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.